242 related articles for article (PubMed ID: 10722429)
1. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
Garbutt JM; Ventrapragada M; Littenberg B; Mundy LM
Clin Infect Dis; 2000 Mar; 30(3):466-72. PubMed ID: 10722429
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
3. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
Lodise TP; McKinnon PS; Tam VH; Rybak MJ
Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
[TBL] [Abstract][Full Text] [Related]
5. Mortality due to vancomycin-resistant enterococcal bacteremia versus vancomycin-susceptible enterococcal bacteremia: an ecological analysis.
Hurley JC
Clin Infect Dis; 2005 Nov; 41(10):1541-2. PubMed ID: 16231272
[No Abstract] [Full Text] [Related]
6. Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia?
Krcmery V; Bilíková E; Svetlansky I; Kovacicová G
Clin Infect Dis; 2001 Apr; 32(7):1110-2. PubMed ID: 11264043
[No Abstract] [Full Text] [Related]
7. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization.
Webb M; Riley LW; Roberts RB
Clin Infect Dis; 2001 Aug; 33(4):445-52. PubMed ID: 11462178
[TBL] [Abstract][Full Text] [Related]
8. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
[TBL] [Abstract][Full Text] [Related]
9. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
[TBL] [Abstract][Full Text] [Related]
10. Unusual increase of vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a university hospital in Taiwan.
Chiang PC; Wu TL; Su JY; Huang YC; Chiu YP; Chia JH; Kuo AJ; Su LH
Chang Gung Med J; 2007; 30(6):493-503. PubMed ID: 18350732
[TBL] [Abstract][Full Text] [Related]
11. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
12. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
Erlandson KM; Sun J; Iwen PC; Rupp ME
Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
[TBL] [Abstract][Full Text] [Related]
13. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
Forrest GN; Arnold RS; Gammie JS; Gilliam BL
J Infect; 2011 Dec; 63(6):420-8. PubMed ID: 21920382
[TBL] [Abstract][Full Text] [Related]
14. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
[No Abstract] [Full Text] [Related]
16. Invasive infections due to vancomycin-resistant enterococci in adult patients.
Jean SS; Fang CT; Wang HK; Hsue PR; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Dec; 34(4):281-6. PubMed ID: 11825009
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
Zeana C; Kubin CJ; Della-Latta P; Hammer SM
Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
[TBL] [Abstract][Full Text] [Related]
20. First recurrent infection with vancomycin-resistant enterococcus from Turkey.
Citak EC; Oguz A; Karadeniz C; Okur V; Basustaoglu A; Arman D
J Infect; 2006 Sep; 53(3):e147-50. PubMed ID: 16413059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]